BlueCrest Capital Management’s St Jude Medical STJ Stock Holding History

BlueCrest Capital Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-6,532	Closed	-$359K	–	1168
2016 Q1	$359K	Buy	+6,532	New	+$356K	0.02%	559
2015 Q4	–	Sell	-9,502	Closed	-$599K	–	1309
2015 Q3	$599K	Buy	+9,502	New	+$678K	0.02%	559
2015 Q2	–	Sell	-24,502	Closed	-$1.6M	–	1011
2015 Q1	$1.6M	Buy	24,502 +17,307	+241%	+$1.15M	0.09%	291
2014 Q4	$468K	Sell	7,195 -296	-4%	-$19.1K	0.01%	455
2014 Q3	$450K	Buy	+7,491	New	+$489K	0.02%	424

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlueCrest Capital Management's STJ Position: Q2 2016 in Review

BlueCrest Capital Management sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 6,532 shares — an estimated $359K sold.

BlueCrest Capital Management first reported a position in STJ in Q3 2014 and held it in 5 quarters. The position peaked at $1.6M in Q1 2015. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

BlueCrest Capital Management reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
BlueCrest Capital Management sold 6,532 St Jude Medical shares in Q2 2016, an estimated $359K.
BlueCrest Capital Management first reported a position in St Jude Medical in Q3 2014 and held it in 5 quarters.
BlueCrest Capital Management's St Jude Medical position peaked at $1.6M in Q1 2015.
615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on BlueCrest Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.